These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35951447)

  • 1. Utilizing Laboratory Results to Identify Emergency Department Patients with Indications for HIV Pre-Exposure Prophylaxis.
    Carlisle NA; Booth JS; Rodgers JB; Heath SL; Walter LA
    AIDS Patient Care STDS; 2022 Aug; 36(8):285-290. PubMed ID: 35951447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated proportion of an urban academic emergency department patient population eligible for HIV preexposure prophylaxis.
    Faryar KA; Ancona RM; Braun RS; Brown JL; Sickles RK; Lyons MS
    Am J Emerg Med; 2021 Oct; 48():198-202. PubMed ID: 33975131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
    Bazzi AR; Biancarelli DL; Childs E; Drainoni ML; Edeza A; Salhaney P; Mimiaga MJ; Biello KB
    AIDS Patient Care STDS; 2018 Dec; 32(12):529-537. PubMed ID: 30311777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Screening for HIV Pre-Exposure Prophylaxis Eligibility in Two Emergency Departments in Washington, DC.
    Kulie P; Castel AD; Zheng Z; Powell NN; Srivastava A; Chandar S; McCarthy ML
    AIDS Patient Care STDS; 2020 Dec; 34(12):516-522. PubMed ID: 33296271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an inner city HIV pre-exposure prophylaxis service tailored to the needs of people who inject drugs.
    Grimshaw C; Boyd L; Smith M; Estcourt CS; Metcalfe R
    HIV Med; 2021 Nov; 22(10):965-970. PubMed ID: 34585494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which Patients in the Emergency Department Should Receive Preexposure Prophylaxis? Implementation of a Predictive Analytics Approach.
    Ridgway JP; Almirol EA; Bender A; Richardson A; Schmitt J; Friedman E; Lancki N; Leroux I; Pieroni N; Dehlin J; Schneider JA
    AIDS Patient Care STDS; 2018 May; 32(5):202-207. PubMed ID: 29672136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA.
    Barry MP; Austin EJ; Bhatraju EP; Glick SN; Stekler JD; Tung EL; Hansen RN; Williams EC; Gojic AJ; Pickering EI; Tsui JI
    Harm Reduct J; 2022 Nov; 19(1):121. PubMed ID: 36320005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Exploration of Factors Impacting Preexposure Prophylaxis Eligibility and Access Among Syringe Exchange Users.
    Roth AM; Aumaier BL; Felsher MA; Welles SL; Martinez-Donate AP; Chavis M; Van Der Pol B
    Sex Transm Dis; 2018 Apr; 45(4):217-221. PubMed ID: 29465703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV Pre-exposure Prophylaxis for People Who Inject Drugs: The Context of Co-occurring Injection- and Sexual-Related HIV Risk in the U.S. Northeast.
    Edeza A; Bazzi A; Salhaney P; Biancarelli D; Childs E; Mimiaga MJ; Drainoni ML; Biello K
    Subst Use Misuse; 2020; 55(4):525-533. PubMed ID: 31596171
    [No Abstract]   [Full Text] [Related]  

  • 10. Low PrEP Awareness and Use Among People Who Inject Drugs, San Francisco, 2018.
    McFarland W; Lin J; Santos GM; Arayasirikul S; Raymond HF; Wilson E
    AIDS Behav; 2020 May; 24(5):1290-1293. PubMed ID: 31563984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship Between Polysubstance Injection Drug Use, HIV Risk Behaviors, and Interest in Pre-Exposure Prophylaxis (PrEP) Among People Who Inject Drugs in Rural West Virginia.
    Schneider KE; White RH; Musci RJ; O'Rourke A; Kilkenny ME; Sherman SG; Allen ST
    J Stud Alcohol Drugs; 2020 Nov; 81(6):740-749. PubMed ID: 33308403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief Report: Use of Pre-Exposure Prophylaxis to Prevent Rapid HIV Transmission Among People Who Inject Drugs in Rural Counties in the United States: A Modeling Study.
    Jacka BP; Nolen S; Bessey SE; Zang X; Goedel WC; Yedinak JL; Marshall BDL
    J Acquir Immune Defic Syndr; 2022 Dec; 91(5):449-452. PubMed ID: 36150038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missed opportunities for healthcare providers to discuss HIV preexposure prophylaxis with people who inject drugs.
    Vincent W; McFarland W
    Int J Drug Policy; 2022 Dec; 110():103873. PubMed ID: 36252292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptance of HIV pre-exposure prophylaxis (PrEP) referral among a sample of PrEP-eligible emergency department patients.
    Faryar KA; Braun R; Ancona RM; Freiermuth C; Lyons MS
    Am J Emerg Med; 2022 Oct; 60():152-155. PubMed ID: 35973343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic Review of HIV Pre-exposure Prophylaxis (PrEP) Implementation in U.S. Emergency Departments: Patient Screening, Prescribing, and Linkage to Care.
    Jackson KJ; Chitle P; McCoy SI; White DAE
    J Community Health; 2024 Jun; 49(3):499-513. PubMed ID: 38127296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an Electronic Algorithm for Identifying Cisgender Female Pre-Exposure Prophylaxis Candidates.
    Ridgway JP; Friedman EE; Bender A; Schmitt J; Cronin M; Brown RN; Johnson AK; Hirschhorn LR
    AIDS Patient Care STDS; 2021 Jan; 35(1):5-8. PubMed ID: 33400588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural vulnerabilities and PrEP awareness among Boston heterosexuals and people who inject drugs at risk for HIV: findings from 2018 to 2019 cycles from the Boston, MA site of the NHBS.
    Lee JS; Batchelder AW; Stanton AM; Westphal L; Klevens RM; Mayer KH; O'Cleirigh C;
    AIDS Care; 2024 May; 36(5):641-651. PubMed ID: 38091449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review.
    Mistler CB; Copenhaver MM; Shrestha R
    AIDS Behav; 2021 May; 25(5):1490-1506. PubMed ID: 32749627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up after voluntary human immunodeficiency virus/sexually transmitted infection counseling, point-of-service testing, and referral to substance abuse treatment from the emergency department.
    Bernstein E; Heeren T; Winter M; Ashong D; Bliss C; Madico G; Ayalew B; Bernstein J
    Acad Emerg Med; 2012 Apr; 19(4):386-95. PubMed ID: 22506942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of Potential Discriminatory HIV Pre-Exposure Prophylaxis (PrEP) Prescribing Practices for People Who Inject Drugs Among a Small Percentage of Providers in the U.S.
    Pleuhs B; Mistler CB; Quinn KG; Dickson-Gomez J; Walsh JL; Petroll AE; John SA
    J Prim Care Community Health; 2022; 13():21501319211063999. PubMed ID: 35068243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.